Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21d03c7c814b4a81ce7bdb05b212d857 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2330-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y115-01001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate |
2015-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5b19f23e5318c329174771e321ff037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b411792e8f23f6f3b166efa270473de5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56516adb4ec729a44c873b289f8b718f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7988b46617af4bd6fcfa7bfe32bf96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b4e3b81bca6955cf9c10d0d8f76a0d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f1e952aeac1a75bfb96fb5b672c9030 |
publicationDate |
2020-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10597660-B2 |
titleOfInvention |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
abstract |
The present invention relates to small interfering RNA (siRNA) molecules against the SOD1 gene, adeno-associated viral (AAV) vectors encoding siRNA molecules and methods for treating amyotrophic lateral sclerosis (ALS) using the siRNA molecules and AAV vectors. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11649459-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023042178-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11459558-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11434502-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11603542-B2 |
priorityDate |
2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |